metoprolol and other beta-adrenergic blocking drugs are known to exert cardioprotective effects that include significant reduction in occurrence of ventricular fibrillation ( vf ) following myocardial ischemia and infarction .
C0025859
metoprolol
C0042510
ventricular fibrillation